HEADER ISOMERASE/IMMUNE SYSTEM 28-JUN-99 1QTL OBSLTE 02-DEC-99 1QTL 1C5F TITLE CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM TITLE 2 BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYLPROLYL ISOMERASE CYP-1; COMPND 3 CHAIN: A, C, E, G, I, K, M, O; COMPND 4 FRAGMENT: CYCLOPHILIN-LIKE DOMAIN, RESIDUES 1-177; COMPND 5 SYNONYM: CYCLOPHILIN, PEPTIDYLPROLYL CIS-TRANS ISOMERASE, COMPND 6 PPIASE; COMPND 7 EC: 5.2.1.8; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CYCLOSPORIN A; COMPND 11 CHAIN: B, D, F, H, J, L, N, P; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BRUGIA MALAYI; SOURCE 3 ORGANISM_COMMON: FILARIAL NEMATODE; SOURCE 4 ATCC: 75593; SOURCE 5 GENE: BMCYP-1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: BACTERIA; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ER2267; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: DOUBLE STRAND VECTOR (TAC, SOURCE 10 PMB1 AND AMPR); SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PMAL-C2; SOURCE 13 EXPRESSION_SYSTEM_GENE: MBP FUSION PROTEIN; SOURCE 14 MOL_ID: 2; SOURCE 15 SYNTHETIC: YES; SOURCE 16 OTHER_DETAILS: CYCLOSPORIN A OCCURS NATURALLY IN THE SOURCE 17 FUNGUS TOLYPOCLADIUM INFLATUM. KEYWDS ISOMERASE, PEPTIDYL-PROLYL CIS-TRANS, PEPTIDYLPROLYL KEYWDS 2 ISOMERASE, CYCLOSPORIN EXPDTA X-RAY DIFFRACTION AUTHOR P.J.ELLIS,C.K.S.CARLOW,D.MA,P.KUHN REVDAT 2 02-DEC-99 1QTL 1 OBSLTE REVDAT 1 02-JUL-99 1QTL 0 JRNL AUTH P.J.ELLIS,C.K.S.CARLOW,D.MA,P.KUHN JRNL TITL CRYSTAL STRUCTURE OF THE COMPLEX OF BRUGIA MALAYI JRNL TITL 2 CYCLOPHILIN AND CYCLOSPORIN A JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 56200 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 2845 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.47 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.58 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5047 REMARK 3 BIN R VALUE (WORKING SET) : 0.3090 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.92 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 261 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 11437 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -13.63700 REMARK 3 B22 (A**2) : 3.10100 REMARK 3 B33 (A**2) : 10.53600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.39300 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.010 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.860 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.650 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 42.82 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED MAXIMUM LIKELIHOOD TARGET BASED REMARK 3 ON STRUCTURE FACTORS WITH NO CUTOFFS REMARK 4 REMARK 4 1QTL COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-1999. REMARK 100 THE RCSB ID CODE IS RCSB009251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUL-1998 REMARK 200 TEMPERATURE (KELVIN) : 105.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : 9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : MOSFLM/SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56200 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.470 REMARK 200 RESOLUTION RANGE LOW (A) : 47.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.37200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, CALCIUM ACETATE, REMARK 280 METHANOL, MES, PH 6.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.08013 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 16CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, REMARK 350 J, K, L, M, N, O, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET E 1 REMARK 465 SER E 2 REMARK 465 LYS E 3 REMARK 465 MET G 1 REMARK 465 SER G 2 REMARK 465 LYS G 3 REMARK 465 LYS G 4 REMARK 465 ASP G 5 REMARK 465 MET I 1 REMARK 465 SER I 2 REMARK 465 LYS I 3 REMARK 465 LYS I 4 REMARK 465 MET K 1 REMARK 465 SER K 2 REMARK 465 MET M 1 REMARK 465 SER M 2 REMARK 465 MET O 1 REMARK 465 SER O 2 REMARK 465 LYS O 3 REMARK 465 LYS O 4 REMARK 465 ASP O 5 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O GLY A 115 OG1 THR A 118 2.19 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG1 THR G 151 OG1 THR K 151 1565 1.82 REMARK 500 OE1 GLU M 148 O HOH 184 1545 2.04 REMARK 500 O HOH 122 O HOH 145 1545 2.10 REMARK 500 OG1 THR M 151 OG1 THR O 151 1545 2.12 REMARK 500 CE2 TYR M 155 O HOH 232 1545 2.14 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET I 72 SD MET I 72 CE -0.047 REMARK 500 MET I 101 SD MET I 101 CE 0.065 REMARK 500 MET K 25 SD MET K 25 CE 0.076 REMARK 500 MET K 101 SD MET K 101 CE 0.050 REMARK 500 MET O 72 SD MET O 72 CE 0.042 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 48 N - CA - C ANGL. DEV. = 7.9 DEGREES REMARK 500 PHE A 64 N - CA - C ANGL. DEV. =-11.4 DEGREES REMARK 500 HIS A 65 N - CA - C ANGL. DEV. = 8.2 DEGREES REMARK 500 VAL A 108 N - CA - C ANGL. DEV. = -9.3 DEGREES REMARK 500 ALA A 112 N - CA - C ANGL. DEV. = -9.4 DEGREES REMARK 500 ILE A 170 N - CA - C ANGL. DEV. = -9.2 DEGREES REMARK 500 PHE C 64 N - CA - C ANGL. DEV. = -9.5 DEGREES REMARK 500 GLU C 97 N - CA - C ANGL. DEV. = -7.9 DEGREES REMARK 500 ALA C 112 N - CA - C ANGL. DEV. =-10.1 DEGREES REMARK 500 PHE E 64 N - CA - C ANGL. DEV. =-12.2 DEGREES REMARK 500 ILE G 15 N - CA - C ANGL. DEV. = -8.2 DEGREES REMARK 500 PHE G 64 N - CA - C ANGL. DEV. = -8.1 DEGREES REMARK 500 ILE G 170 N - CA - C ANGL. DEV. = -8.4 DEGREES REMARK 500 ASP I 12 N - CA - C ANGL. DEV. =-11.5 DEGREES REMARK 500 PHE I 64 N - CA - C ANGL. DEV. = -8.9 DEGREES REMARK 500 GLY I 85 N - CA - C ANGL. DEV. = 9.2 DEGREES REMARK 500 VAL I 108 N - CA - C ANGL. DEV. = -8.4 DEGREES REMARK 500 ALA I 112 N - CA - C ANGL. DEV. =-11.9 DEGREES REMARK 500 GLU K 26 N - CA - C ANGL. DEV. = -8.4 DEGREES REMARK 500 PHE K 64 N - CA - C ANGL. DEV. =-11.5 DEGREES REMARK 500 ASP K 95 N - CA - C ANGL. DEV. = 8.1 DEGREES REMARK 500 PHE M 64 N - CA - C ANGL. DEV. =-10.9 DEGREES REMARK 500 ILE M 73 N - CA - C ANGL. DEV. = -8.6 DEGREES REMARK 500 GLU M 97 N - CA - C ANGL. DEV. = -8.0 DEGREES REMARK 500 ALA M 112 N - CA - C ANGL. DEV. = -8.0 DEGREES REMARK 500 ILE M 170 N - CA - C ANGL. DEV. = -8.2 DEGREES REMARK 500 PHE O 64 N - CA - C ANGL. DEV. =-11.3 DEGREES REMARK 500 ALA O 112 N - CA - C ANGL. DEV. = -8.2 DEGREES REMARK 500 ILE O 170 N - CA - C ANGL. DEV. =-13.2 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 DAL B 8 -131.73 85.79 REMARK 500 DAL D 8 -130.92 100.67 REMARK 500 DAL F 8 -125.92 89.39 REMARK 500 DAL H 8 -136.22 93.25 REMARK 500 DAL J 8 -133.60 91.36 REMARK 500 DAL L 8 -132.03 85.10 REMARK 500 DAL N 8 -135.47 95.18 REMARK 500 DAL P 8 -129.18 98.52 DBREF 1QTL A 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1QTL C 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1QTL E 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1QTL G 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1QTL I 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1QTL K 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1QTL M 1 177 UNP Q27450 CYP1_BRUMA 1 177 DBREF 1QTL O 1 177 UNP Q27450 CYP1_BRUMA 1 177 SEQRES 1 A 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 A 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 A 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 A 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 A 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 A 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 A 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 A 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 A 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 A 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 A 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 A 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 A 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 A 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 B 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA SEQRES 1 C 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 C 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 C 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 C 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 C 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 C 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 C 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 C 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 C 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 C 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 C 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 C 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 C 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 C 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 D 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA SEQRES 1 E 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 E 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 E 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 E 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 E 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 E 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 E 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 E 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 E 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 E 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 E 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 E 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 E 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 E 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 F 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA SEQRES 1 G 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 G 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 G 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 G 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 G 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 G 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 G 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 G 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 G 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 G 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 G 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 G 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 G 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 G 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 H 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA SEQRES 1 I 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 I 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 I 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 I 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 I 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 I 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 I 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 I 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 I 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 I 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 I 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 I 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 I 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 I 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 J 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA SEQRES 1 K 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 K 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 K 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 K 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 K 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 K 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 K 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 K 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 K 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 K 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 K 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 K 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 K 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 K 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 L 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA SEQRES 1 M 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 M 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 M 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 M 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 M 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 M 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 M 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 M 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 M 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 M 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 M 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 M 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 M 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 M 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 N 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA SEQRES 1 O 177 MET SER LYS LYS ASP ARG ARG ARG VAL PHE LEU ASP VAL SEQRES 2 O 177 THR ILE ASP GLY ASN LEU ALA GLY ARG ILE VAL MET GLU SEQRES 3 O 177 LEU TYR ASN ASP ILE ALA PRO ARG THR CYS ASN ASN PHE SEQRES 4 O 177 LEU MET LEU CYS THR GLY MET ALA GLY THR GLY LYS ILE SEQRES 5 O 177 SER GLY LYS PRO LEU HIS TYR LYS GLY SER THR PHE HIS SEQRES 6 O 177 ARG VAL ILE LYS ASN PHE MET ILE GLN GLY GLY ASP PHE SEQRES 7 O 177 THR LYS GLY ASP GLY THR GLY GLY GLU SER ILE TYR GLY SEQRES 8 O 177 GLY MET PHE ASP ASP GLU GLU PHE VAL MET LYS HIS ASP SEQRES 9 O 177 GLU PRO PHE VAL VAL SER MET ALA ASN LYS GLY PRO ASN SEQRES 10 O 177 THR ASN GLY SER GLN PHE PHE ILE THR THR THR PRO ALA SEQRES 11 O 177 PRO HIS LEU ASN ASN ILE HIS VAL VAL PHE GLY LYS VAL SEQRES 12 O 177 VAL SER GLY GLN GLU VAL VAL THR LYS ILE GLU TYR LEU SEQRES 13 O 177 LYS THR ASN SER LYS ASN ARG PRO LEU ALA ASP VAL VAL SEQRES 14 O 177 ILE LEU ASN CYS GLY GLU LEU VAL SEQRES 1 P 11 BMT ABA SAR MLE VAL MLE ALA DAL MLE MLE MVA MODRES 1QTL BMT B 1 THR MODRES 1QTL ABA B 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR B 3 GLY SARCOSINE MODRES 1QTL MLE B 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE B 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL B 8 ALA D-ALANINE MODRES 1QTL MLE B 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE B 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA B 11 VAL N-METHYLVALINE MODRES 1QTL BMT D 1 THR MODRES 1QTL ABA D 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR D 3 GLY SARCOSINE MODRES 1QTL MLE D 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE D 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL D 8 ALA D-ALANINE MODRES 1QTL MLE D 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE D 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA D 11 VAL N-METHYLVALINE MODRES 1QTL BMT F 1 THR MODRES 1QTL ABA F 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR F 3 GLY SARCOSINE MODRES 1QTL MLE F 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE F 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL F 8 ALA D-ALANINE MODRES 1QTL MLE F 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE F 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA F 11 VAL N-METHYLVALINE MODRES 1QTL BMT H 1 THR MODRES 1QTL ABA H 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR H 3 GLY SARCOSINE MODRES 1QTL MLE H 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE H 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL H 8 ALA D-ALANINE MODRES 1QTL MLE H 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE H 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA H 11 VAL N-METHYLVALINE MODRES 1QTL BMT J 1 THR MODRES 1QTL ABA J 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR J 3 GLY SARCOSINE MODRES 1QTL MLE J 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE J 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL J 8 ALA D-ALANINE MODRES 1QTL MLE J 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE J 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA J 11 VAL N-METHYLVALINE MODRES 1QTL BMT L 1 THR MODRES 1QTL ABA L 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR L 3 GLY SARCOSINE MODRES 1QTL MLE L 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE L 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL L 8 ALA D-ALANINE MODRES 1QTL MLE L 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE L 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA L 11 VAL N-METHYLVALINE MODRES 1QTL BMT N 1 THR MODRES 1QTL ABA N 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR N 3 GLY SARCOSINE MODRES 1QTL MLE N 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE N 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL N 8 ALA D-ALANINE MODRES 1QTL MLE N 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE N 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA N 11 VAL N-METHYLVALINE MODRES 1QTL BMT P 1 THR MODRES 1QTL ABA P 2 ALA ALPHA-AMINOBUTYRIC ACID MODRES 1QTL SAR P 3 GLY SARCOSINE MODRES 1QTL MLE P 4 LEU N-METHYLLEUCINE MODRES 1QTL MLE P 6 LEU N-METHYLLEUCINE MODRES 1QTL DAL P 8 ALA D-ALANINE MODRES 1QTL MLE P 9 LEU N-METHYLLEUCINE MODRES 1QTL MLE P 10 LEU N-METHYLLEUCINE MODRES 1QTL MVA P 11 VAL N-METHYLVALINE HET BMT B 1 13 HET ABA B 2 6 HET SAR B 3 5 HET MLE B 4 9 HET MLE B 6 9 HET DAL B 8 5 HET MLE B 9 9 HET MLE B 10 9 HET MVA B 11 8 HET BMT D 1 13 HET ABA D 2 6 HET SAR D 3 5 HET MLE D 4 9 HET MLE D 6 9 HET DAL D 8 5 HET MLE D 9 9 HET MLE D 10 9 HET MVA D 11 8 HET BMT F 1 13 HET ABA F 2 6 HET SAR F 3 5 HET MLE F 4 9 HET MLE F 6 9 HET DAL F 8 5 HET MLE F 9 9 HET MLE F 10 9 HET MVA F 11 8 HET BMT H 1 13 HET ABA H 2 6 HET SAR H 3 5 HET MLE H 4 9 HET MLE H 6 9 HET DAL H 8 5 HET MLE H 9 9 HET MLE H 10 9 HET MVA H 11 8 HET BMT J 1 13 HET ABA J 2 6 HET SAR J 3 5 HET MLE J 4 9 HET MLE J 6 9 HET DAL J 8 5 HET MLE J 9 9 HET MLE J 10 9 HET MVA J 11 8 HET BMT L 1 13 HET ABA L 2 6 HET SAR L 3 5 HET MLE L 4 9 HET MLE L 6 9 HET DAL L 8 5 HET MLE L 9 9 HET MLE L 10 9 HET MVA L 11 8 HET BMT N 1 13 HET ABA N 2 6 HET SAR N 3 5 HET MLE N 4 9 HET MLE N 6 9 HET DAL N 8 5 HET MLE N 9 9 HET MLE N 10 9 HET MVA N 11 8 HET BMT P 1 13 HET ABA P 2 6 HET SAR P 3 5 HET MLE P 4 9 HET MLE P 6 9 HET DAL P 8 5 HET MLE P 9 9 HET MLE P 10 9 HET MVA P 11 8 HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE HETNAM MLE N-METHYLLEUCINE HETNAM DAL D-ALANINE HETNAM MVA N-METHYLVALINE FORMUL 2 BMT 8(C10 H19 N O3) FORMUL 2 ABA 8(C4 H9 N O2) FORMUL 2 SAR 8(C3 H7 N O2) FORMUL 2 MLE 32(C7 H15 N O2) FORMUL 2 DAL 8(C3 H7 N O2) FORMUL 2 MVA 8(C6 H13 N O2) FORMUL 17 HOH *337(H2 O1) HELIX 1 1 SER A 2 ARG A 6 5 5 HELIX 2 2 ALA A 32 GLY A 45 1 14 HELIX 3 3 ALA A 130 ASN A 134 5 5 HELIX 4 4 GLY A 146 TYR A 155 1 10 HELIX 5 5 SER C 2 ARG C 6 5 5 HELIX 6 6 ALA C 32 GLY C 45 1 14 HELIX 7 7 ALA C 130 ASN C 134 5 5 HELIX 8 8 GLY C 146 TYR C 155 1 10 HELIX 9 9 ALA E 32 GLY E 45 1 14 HELIX 10 10 ALA E 130 ASN E 134 5 5 HELIX 11 11 GLY E 146 TYR E 155 1 10 HELIX 12 12 ALA G 32 GLY G 45 1 14 HELIX 13 13 ALA G 130 ASN G 134 5 5 HELIX 14 14 GLY G 146 TYR G 155 1 10 HELIX 15 15 ALA I 32 GLY I 45 1 14 HELIX 16 16 ALA I 130 ASN I 134 5 5 HELIX 17 17 GLY I 146 TYR I 155 1 10 HELIX 18 18 ALA K 32 GLY K 45 1 14 HELIX 19 19 ALA K 130 ASN K 134 5 5 HELIX 20 20 GLY K 146 TYR K 155 1 10 HELIX 21 21 ALA M 32 GLY M 45 1 14 HELIX 22 22 ALA M 130 ASN M 134 5 5 HELIX 23 23 GLY M 146 TYR M 155 1 10 HELIX 24 24 ALA O 32 GLY O 45 1 14 HELIX 25 25 ALA O 130 ASN O 134 5 5 HELIX 26 26 GLY O 146 TYR O 155 1 10 SHEET 1 A 8 ARG A 66 ILE A 68 0 SHEET 2 A 8 MET A 72 GLY A 75 -1 O MET A 72 N ILE A 68 SHEET 3 A 8 PHE A 123 THR A 126 -1 N PHE A 123 O GLY A 75 SHEET 4 A 8 VAL A 108 MET A 111 -1 O VAL A 108 N THR A 126 SHEET 5 A 8 VAL A 139 SER A 145 -1 N PHE A 140 O VAL A 109 SHEET 6 A 8 ASN A 18 LEU A 27 -1 N VAL A 24 O SER A 145 SHEET 7 A 8 ARG A 8 ILE A 15 -1 O VAL A 9 N MET A 25 SHEET 8 A 8 VAL A 168 GLU A 175 -1 N VAL A 169 O THR A 14 SHEET 1 B 8 PHE C 64 ILE C 68 0 SHEET 2 B 8 MET C 72 GLY C 75 -1 O MET C 72 N ILE C 68 SHEET 3 B 8 PHE C 123 THR C 126 -1 O PHE C 123 N GLY C 75 SHEET 4 B 8 VAL C 108 MET C 111 -1 O VAL C 108 N THR C 126 SHEET 5 B 8 VAL C 139 SER C 145 -1 N PHE C 140 O VAL C 109 SHEET 6 B 8 ASN C 18 LEU C 27 -1 N VAL C 24 O SER C 145 SHEET 7 B 8 ARG C 8 ILE C 15 -1 O VAL C 9 N MET C 25 SHEET 8 B 8 VAL C 168 GLU C 175 -1 N VAL C 169 O THR C 14 SHEET 1 C 8 ARG E 66 ILE E 68 0 SHEET 2 C 8 MET E 72 GLY E 75 -1 O MET E 72 N ILE E 68 SHEET 3 C 8 PHE E 123 THR E 126 -1 N PHE E 123 O GLY E 75 SHEET 4 C 8 VAL E 108 MET E 111 -1 O VAL E 108 N THR E 126 SHEET 5 C 8 VAL E 139 SER E 145 -1 N PHE E 140 O VAL E 109 SHEET 6 C 8 ASN E 18 LEU E 27 -1 O VAL E 24 N VAL E 144 SHEET 7 C 8 ARG E 7 ILE E 15 -1 O ARG E 7 N LEU E 27 SHEET 8 C 8 VAL E 168 GLU E 175 -1 O VAL E 169 N THR E 14 SHEET 1 D 8 ARG G 66 ILE G 68 0 SHEET 2 D 8 MET G 72 GLY G 75 -1 O MET G 72 N ILE G 68 SHEET 3 D 8 PHE G 123 THR G 126 -1 O PHE G 123 N GLY G 75 SHEET 4 D 8 VAL G 108 MET G 111 -1 O VAL G 108 N THR G 126 SHEET 5 D 8 VAL G 139 SER G 145 -1 N PHE G 140 O VAL G 109 SHEET 6 D 8 ASN G 18 LEU G 27 -1 O VAL G 24 N VAL G 144 SHEET 7 D 8 ARG G 7 ILE G 15 -1 O ARG G 7 N LEU G 27 SHEET 8 D 8 VAL G 168 LEU G 176 -1 N VAL G 169 O THR G 14 SHEET 1 E 8 ARG I 66 ILE I 68 0 SHEET 2 E 8 MET I 72 GLY I 75 -1 O MET I 72 N ILE I 68 SHEET 3 E 8 PHE I 123 THR I 126 -1 N PHE I 123 O GLY I 75 SHEET 4 E 8 VAL I 108 MET I 111 -1 O VAL I 108 N THR I 126 SHEET 5 E 8 VAL I 139 SER I 145 -1 N PHE I 140 O VAL I 109 SHEET 6 E 8 ASN I 18 LEU I 27 -1 N VAL I 24 O SER I 145 SHEET 7 E 8 ARG I 8 ILE I 15 -1 N VAL I 9 O MET I 25 SHEET 8 E 8 VAL I 168 GLU I 175 -1 N VAL I 169 O THR I 14 SHEET 1 F 8 ARG K 66 ILE K 68 0 SHEET 2 F 8 MET K 72 GLY K 75 -1 O MET K 72 N ILE K 68 SHEET 3 F 8 PHE K 123 THR K 126 -1 O PHE K 123 N GLY K 75 SHEET 4 F 8 VAL K 108 MET K 111 -1 O VAL K 108 N THR K 126 SHEET 5 F 8 VAL K 139 SER K 145 -1 N PHE K 140 O VAL K 109 SHEET 6 F 8 ASN K 18 LEU K 27 -1 N VAL K 24 O SER K 145 SHEET 7 F 8 ARG K 7 ILE K 15 -1 O ARG K 7 N LEU K 27 SHEET 8 F 8 VAL K 168 GLU K 175 -1 O VAL K 169 N THR K 14 SHEET 1 G 8 PHE M 64 ILE M 68 0 SHEET 2 G 8 MET M 72 GLY M 75 -1 O MET M 72 N ILE M 68 SHEET 3 G 8 PHE M 123 THR M 126 -1 N PHE M 123 O GLY M 75 SHEET 4 G 8 VAL M 108 MET M 111 -1 O VAL M 108 N THR M 126 SHEET 5 G 8 VAL M 139 SER M 145 -1 N PHE M 140 O VAL M 109 SHEET 6 G 8 ASN M 18 LEU M 27 -1 N VAL M 24 O SER M 145 SHEET 7 G 8 ARG M 8 ILE M 15 -1 O VAL M 9 N MET M 25 SHEET 8 G 8 VAL M 168 GLU M 175 -1 O VAL M 169 N THR M 14 SHEET 1 H 8 ARG O 66 ILE O 68 0 SHEET 2 H 8 MET O 72 GLY O 75 -1 O MET O 72 N ILE O 68 SHEET 3 H 8 PHE O 123 THR O 126 -1 N PHE O 123 O GLY O 75 SHEET 4 H 8 VAL O 108 MET O 111 -1 O VAL O 108 N THR O 126 SHEET 5 H 8 VAL O 139 SER O 145 -1 N PHE O 140 O VAL O 109 SHEET 6 H 8 ASN O 18 LEU O 27 -1 O VAL O 24 N VAL O 144 SHEET 7 H 8 ARG O 7 ILE O 15 -1 O ARG O 7 N LEU O 27 SHEET 8 H 8 VAL O 168 GLU O 175 -1 N VAL O 169 O THR O 14 LINK N BMT B 1 C MVA B 11 LINK N BMT D 1 C MVA D 11 LINK N BMT F 1 C MVA F 11 LINK N BMT H 1 C MVA H 11 LINK N BMT J 1 C MVA J 11 LINK N BMT L 1 C MVA L 11 LINK N BMT N 1 C MVA N 11 LINK N BMT P 1 C MVA P 11 CRYST1 62.000 101.160 133.920 90.00 93.75 90.00 P 1 21 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016129 0.000000 0.001057 0.00000 SCALE2 0.000000 0.009984 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007483 0.00000